These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 34993923)
1. In vitro release, ex vivo penetration, and in vivo dermatokinetics of ketoconazole-loaded solid lipid nanoparticles for topical delivery. Ramzan M; Gourion-Arsiquaud S; Hussain A; Gulati JS; Zhang Q; Trehan S; Puri V; Michniak-Kohn B; Kaur IP Drug Deliv Transl Res; 2022 Jul; 12(7):1659-1683. PubMed ID: 34993923 [TBL] [Abstract][Full Text] [Related]
2. Lipid-polyethylene glycol based nano-ocular formulation of ketoconazole. Kakkar S; Karuppayil SM; Raut JS; Giansanti F; Papucci L; Schiavone N; Kaur IP Int J Pharm; 2015 Nov; 495(1):276-289. PubMed ID: 26325312 [TBL] [Abstract][Full Text] [Related]
3. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization, Patel MH; Mundada VP; Sawant KK Drug Dev Ind Pharm; 2019 Aug; 45(8):1242-1257. PubMed ID: 30880488 [No Abstract] [Full Text] [Related]
4. Topical Amphotericin B solid lipid nanoparticles: Design and development. Butani D; Yewale C; Misra A Colloids Surf B Biointerfaces; 2016 Mar; 139():17-24. PubMed ID: 26700229 [TBL] [Abstract][Full Text] [Related]
6. Amelioration of ketoconazole in lipid nanoparticles for enhanced antifungal activity and bioavailability through oral administration for management of fungal infections. Dudhipala N; Ay AA Chem Phys Lipids; 2020 Oct; 232():104953. PubMed ID: 32814084 [TBL] [Abstract][Full Text] [Related]
7. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics. Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995 [TBL] [Abstract][Full Text] [Related]
8. Full factorial design, physicochemical characterization, ex vivo investigation, and biological assessment of glutathione-loaded solid lipid nanoparticles for topical application. Liu M; Sharma M; Lu GL; Zhang Z; Yin N; Wen J Int J Pharm; 2023 Jan; 630():122381. PubMed ID: 36427694 [TBL] [Abstract][Full Text] [Related]
9. Solid lipid nanoparticles for transdermal delivery of avanafil: optimization, formulation, in-vitro and ex-vivo studies. Kurakula M; Ahmed OA; Fahmy UA; Ahmed TA J Liposome Res; 2016 Dec; 26(4):288-96. PubMed ID: 26784833 [TBL] [Abstract][Full Text] [Related]
10. Preparation, in vitro and in vivo Evaluation of Thermosensitive in situ Gel Loaded with Ibuprofen-Solid Lipid Nanoparticles for Rectal Delivery. Huang CH; Hu PY; Wu QY; Xia MY; Zhang WL; Lei ZQ; Li DX; Zhang GS; Feng JF Drug Des Devel Ther; 2022; 16():1407-1431. PubMed ID: 35586185 [TBL] [Abstract][Full Text] [Related]
11. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization. Shazly GA; Alshehri S; Ibrahim MA; Tawfeek HM; Razik JA; Hassan YA; Shakeel F AAPS PharmSciTech; 2018 May; 19(4):1712-1719. PubMed ID: 29532427 [TBL] [Abstract][Full Text] [Related]
13. Histopathological evaluation of caffeine-loaded solid lipid nanoparticles in efficient treatment of cellulite. Hamishehkar H; Shokri J; Fallahi S; Jahangiri A; Ghanbarzadeh S; Kouhsoltani M Drug Dev Ind Pharm; 2015; 41(10):1640-6. PubMed ID: 25382163 [TBL] [Abstract][Full Text] [Related]
14. Impact of Composition and Morphology of Ketoconazole-Loaded Solid Lipid Nanoparticles on Intestinal Permeation and Gastroplus-Based Prediction Studies. Aljurbui SJ; Hussain A; Yusuf M; Ramzan M; Afzal O; Almohaywi B; Yasmin S; Altamimi ASA ACS Omega; 2022 Jul; 7(26):22406-22420. PubMed ID: 35811933 [TBL] [Abstract][Full Text] [Related]
15. Development and In-Vitro Evaluation of Eugenol-Based Nanostructured Lipid Carriers for Effectual Topical Treatment Against C. albicans. Chilamakuri SN; Kumar A; Nath AG; Gupta A; Selvaraju S; Basrani S; Jadhav A; Gulbake A J Pharm Sci; 2024 Mar; 113(3):772-784. PubMed ID: 38043682 [TBL] [Abstract][Full Text] [Related]
16. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation. Dudhipala N; Janga KY; Gorre T Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077 [TBL] [Abstract][Full Text] [Related]
17. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Das S; Ng WK; Tan RB Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358 [TBL] [Abstract][Full Text] [Related]
18. Formulation and in-vivo Evaluation of Novel Topical Gel of Lopinavir for Targeting HIV. Ansari H; Singh P Curr HIV Res; 2018; 16(4):270-279. PubMed ID: 30246641 [TBL] [Abstract][Full Text] [Related]
19. Development characterization and skin permeating potential of lipid based novel delivery system for topical treatment of psoriasis. Pradhan M; Singh D; Singh MR Chem Phys Lipids; 2015 Feb; 186():9-16. PubMed ID: 25447290 [TBL] [Abstract][Full Text] [Related]
20. New Insight for Enhanced Topical Targeting of Caffeine for Effective Cellulite Treatment: In Vitro Characterization, Permeation Studies, and Histological Evaluation in Rats. Fouad SA; Badr TA; Abdelbary A; Fadel M; Abdelmonem R; Jasti BR; El-Nabarawi M AAPS PharmSciTech; 2024 Oct; 25(7):237. PubMed ID: 39384727 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]